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A B S T R A C T
Patients with cerebral small vessel disease (SVD) frequently show decline in cognitive performance. However,
neuroimaging in SVD patients discloses a wide range of brain lesions and alterations so that it is often difficult to
understand which of these changes are the most relevant for cognitive decline. It has also become evident that
visually-rated alterations do not fully explain the neuroimaging correlates of cognitive decline in SVD. Fractal di-
mension (FD), a unitless feature of structural complexity that can be computed from high-resolution T1-weighted
images, has been recently applied to the neuroimaging evaluation of the human brain. Indeed, white matter (WM)
and cortical gray matter (GM) exhibit an inherent structural complexity that can be measured through the FD.
In our study, we included 64 patients (mean age ± standard deviation, 74.6 ± 6.9, education
7.9 ± 4.2 years, 53% males) with SVD and mild cognitive impairment (MCI), and a control group of 24 healthy
subjects (mean age ± standard deviation, 72.3 ± 4.4 years, 50% males). With the aim of assessing whether the
FD values of cerebral WM (WM FD) and cortical GM (GM FD) could be valuable structural predictors of cognitive
performance in patients with SVD and MCI, we employed a machine learning strategy based on LASSO (least
absolute shrinkage and selection operator) regression applied on a set of standard and advanced neuroimaging
features in a nested cross-validation (CV) loop. This approach was aimed at 1) choosing the best predictive
models, able to reliably predict the individual neuropsychological scores sensitive to attention and executive
dysfunctions (prominent features of subcortical vascular cognitive impairment) and 2) identifying a features
ranking according to their importance in the model through the assessment of the out-of-sample error.
For each neuropsychological test, using 1000 repetitions of LASSO regression and 5000 random permutations,
we found that the statistically significant models were those for the Montreal Cognitive Assessment scores (p-
value= .039), Symbol Digit Modalities Test scores (p-value= .039), and Trail Making Test Part A scores (p-
value= .025). Significant prediction of these scores was obtained using different sets of neuroimaging features
in which the WM FD was the most frequently selected feature.
In conclusion, we showed that a machine learning approach could be useful in SVD research field using
standard and advanced neuroimaging features. Our study results raise the possibility that FD may represent a
consistent feature in predicting cognitive decline in SVD that can complement standard imaging.
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1. Introduction
Mild cognitive impairment (MCI) defines a clinical status in which
cognitive deficits are present but their severity, although clinically re-
cognizable, does not impact on the personal autonomy in activities of
daily living, and thus does not reach the level of dementia. Various
dementia subtypes are preceded by an MCI stage (Gauthier et al.,
2006). Small vessel disease (SVD) is recognized as a major cause of
stroke and dementia (Rensma et al., 2018), and has been shown to be
frequently associated with a cognitive impairment mainly characterized
by deficits of attention and executive function (O'Brien et al., 2003;
Pantoni, 2010). Neuroimaging plays today a crucial role in defining the
presence of SVD in patients with cognitive decline in whom it may be
the sole pathological process or coexist with degenerative processes
(Pantoni, 2010). Efforts have been made to harmonize the neuroima-
ging definition of macroscopic lesions underlying SVD on conventional
MRI, including recent small subcortical infarcts, white matter hyper-
intensities (WMH), lacunes, enlarged perivascular spaces (EPVS), cer-
ebral microbleeds, and atrophy (De Guio et al., 2016; Wardlaw et al.,
2013). A consensus paper reporting neuroimaging standards for re-
search in SVD also recognized the importance of new MRI techniques to
evaluate the different expressions of SVD (Wardlaw et al., 2013).
However, it remains unclear, at present, which are the neuroimaging
features that better predict clinical features, particularly cognitive
status. Additionally, both subcortical and cortical changes are today
accepted as features of SVD, but their respective role in terms of clinical
correlates is not yet established. Also, the evaluation of different SVD
features in a single patient is not easy and rather demanding in terms of
time and use of MRI techniques.
During the last 20 years, quantitative assessment of brain volume
using isotropic high-resolution T1-weighted MR images has been largely
applied to evaluate macroscopic structural alterations occurring in both
aging and neurological diseases (Toga and Thompson, 2002). However,
volume assessment does not capture the inherent structural complexity
of the cerebral white matter (WM) and the cortical gray matter (GM).
This complexity may be investigated using fractal geometry, which
describes the complexity of objects that show, in a proper range of
spatial scales, self-similarity, i.e., a geometrical property of objects
composed of subunits and sub-subunits similar to the whole shape
(Mandelbrot, 1967, 1982). The fractal dimension (FD) is a compact,
unitless, geometric shape feature which represents how much the object
fills the space (Tolle et al., 2003) and yields a single quantitative index
of the structural complexity of an object (Zhao et al., 2016). The FD of
cerebral WM and cortical GM can be computed using high-resolution
T1-weighted images commonly employed in SVD and therefore does not
require additional MRI acquisitions.
Both cerebral WM and cortical GM exhibit fractal properties in a
statistical sense (Bullmore et al., 1994; Free et al., 1996; Kiselev et al.,
2003; Majumdar and Prasad, 1988; Zhang et al., 2006). The WM and
GM FD values have been found positively associated with cognitive
performance in aged subjects (Mustafa et al., 2012) and the GM FD also
with the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-cog)
scale in Alzheimer's disease patients (King et al., 2010). Along this line,
it is reasonable to assume that the WM FD and GM FD, as measurements
of the structural complexity of the brain, might represent a potentially
useful feature also in SVD.
The aims of this study were to assess whether the FD of cerebral WM
and/or of cortical GM computed using high-resolution isotropic T1-
weighted MR images are valuable predictors of cognitive performance
in patients with SVD and MCI, and if they are complementary to other
standard neuroimaging features and to WM and GM volumes. We em-
ployed a machine learning strategy based on LASSO (least absolute
shrinkage and selection operator) regression applied on several neu-
roimaging features in a nested cross-validation loop. This approach was
aimed at 1) choosing the best predictive models, able to reliably predict
the individual neuropsychological scores sensitive to attention and
executive dysfunctions (prominent features of subcortical vascular
cognitive impairment) and 2) identifying a features ranking according
to their importance in the model through the assessment of the out-of-
sample error, that is a measure of how accurately a model is able to
predict values for unseen data.
2. Materials and methods
2.1. Participants
In this study, we included 76 patients with evidence of MCI and WM
T2-weighted imaging hyperintensities of presumed vascular origin of
moderate or severe extension who were enrolled in one (Florence) of
the VMCI-Tuscany study centers and who were object of a previous
report (Pasi et al., 2015). Twelve patients were excluded because
FreeSurfer segmentations were not satisfactory after manual editing and
re-running up to three times (see Section 2.4.2 White and gray matter
volumes sub-section below). Final analyses were thus performed on 64
patients. The mean (± standard deviation (SD)) age and years of
education were 74.6 ± 6.9 and 7.9 ± 4.2 years, respectively; 34 pa-
tients (53%) were males.
A control group composed of 24 healthy control subjects (12 men
and 12 women, mean age ± standard deviation 72.5 ± 4.7 years) was
included in the study. No significant difference in age (t-test, p= .07)
and in sex proportion (χ2 test, p= .97) was present between the patient
and control groups. Healthy controls had no familial or personal history
of neurologic or psychiatric disorders, and underwent a neurologic
examination that showed no abnormalities. They were assessed with
Mini Mental State Examination (MMSE) and their score corrected for
age and education level (mean 29.03 ± 1.14, range 26.2–30) resulted
within the normal range for the Italian population (Measso et al., 1993).
Finally, their MRI showed no (in 6 subjects) or mild (in 18 subjects)
brain WMH on T2-weighed fluid-attenuated inversion recovery (FLAIR)
images (according to the modified version of the Fazekas scale (Pantoni
et al., 2005)) without lacunes. Patients and controls underwent the
same imaging protocol on the same scanner, but evaluation of some
standard neuroimaging features of SVD (i.e., cerebral microbleeds,
enlarged perivascular spaces, and quantitative WM lesion load) was
available only for the patient sample as part of the Vascular MCI-Tus-
cany Study protocol (see Section 2.2Vascular MCI-Tuscany Study neu-
ropsychological evaluation and Section 2.3MRI examination sub-sections
below).
2.2. Vascular MCI-Tuscany study neuropsychological evaluation
The Vascular MCI-Tuscany Study is a 3-center, prospective, ob-
servational study aimed at evaluating the determinants of the transition
from vascular MCI to dementia in patients with SVD. The study meth-
odology has been reported in details elsewhere (Poggesi et al., 2012).
The study was conducted in accordance with the Helsinki Declaration
and was approved by the local Ethics Committee. Each patient gave a
written informed consent. To be included, patients had to have: 1) MCI
according to Winblad et al. criteria (Winblad et al., 2004), oper-
ationalized in agreement with Salvadori et al. (Salvadori et al., 2016);
and 2) evidence on MRI of moderate-to-severe WMH on FLAIR T2-
weighed images in agreement with a modified version of the Fazekas
scale (Pantoni et al., 2005). Study inclusion and MRI analysis were
based on the same MRI scans.
According to the study protocol, at baseline, each patient underwent
a comprehensive neuropsychological evaluation by means of the VMCI-
Tuscany neuropsychological battery, that is an extensive tool specifi-
cally developed for patients with SVD and MCI (Salvadori et al., 2015).
The VMCI-Tuscany neuropsychological battery includes both global
cognitive functioning tests and second-level tests covering different
cognitive domains. For the purpose of this study, among the cognitive
tests of the VMCI-Tuscany neuropsychological battery, we selected
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those which are sensitive to attention and executive dysfunctions, be-
cause these are prominent features of subcortical vascular cognitive
impairment (O'Brien et al., 2003). The cognitive tests selected were:
• Montreal Cognitive Assessment (MoCA), a 10-min cognitive
screening tool (Conti et al., 2015; Nasreddine et al., 2005) suggested
by the NINDS-CSN (National Institute for Neurological Disorders
and Stroke and the Canadian Stroke Network) to harmonize stan-
dards for the evaluation of vascular cognitive impairment, because it
includes several items assessing executive functions, attention and
concentration (Hachinski et al., 2006). Total score range is 0–30;
higher scores represent better performance.• Visual Search, for focused attention, a digit cancellation task with a
time limit (Della Sala et al., 1992). The score (range 0–50) is the
number of corrected targets crossed out; higher scores represent
better performance.• Symbol Digit Modalities Test (SDMT), for sustained attention, a
symbol substitution task with a time limit (Nocentini et al., 2006).
The score (range 0–110) is the number of correct answers; higher
scores represent better performance.• Trail Making Test (TMT), Part A, for psychomotor speed, a visual
scanning and tracking task in which participants are asked to con-
nect in order a sequence of 25 numbers (Giovagnoli et al., 1996).
The score is the time in seconds required to complete; higher scores
represent worse performance.• Color Word Stroop Test, for selective attention and response in-
hibition, requires the participants to selectively process the color
features of written words, while continuously blocking out the
processing of reading (Caffarra et al., 2002b). The interference effect
is evaluated by means of execution time in seconds; higher scores
represent worse performance.• Immediate copy of the Rey-Osterrieth Complex Figure (ROCF); de-
spite this test is commonly used for the assessment of visuo-spatial
abilities, there is growing consensus on the fact that its complexity
requires an integrative cognitive approach, and its reproduction
involves also planning and organizational strategies that are related
to executive functions (Caffarra et al., 2002a; Elderkin-Thompson
et al., 2004; Freeman et al., 2000; Salvadori et al., 2018; Shin et al.,
2006). The score (range 0–36) is based on the presence and accuracy
of 18 units of the figure; higher scores represent better performance.
For the neuropsychological tests, we used the available normative
data that are based on healthy Italian adult samples national norms to
calculate demographically-adjusted scores by means of the regression
equations extracted by normative studies (Caffarra et al., 2002a;
Caffarra et al., 2002b; Conti et al., 2015; Della Sala et al., 1992;
Giovagnoli et al., 1996; Nocentini et al., 2006). Since age and level of
education resulted significantly associated with the performance in all
the selected cognitive tests, a factor of correction was applied. For the
visual search test, also sex was found to be a statistically significant
factor, and the corresponding correction was then calculated and ap-
plied (Nocentini et al., 2006).
Fig. 1. Overview of the neuroimaging feature extraction procedure for LASSO (least absolute shrinkage and selection operator) regression. We fitted a separate
regression model for each neuropsychological test. WM and GM volumes are normalized to the estimated intracranial volume (EPVS= enlarged perivascular spaces,
FD= fractal dimension, FLAIR= Fluid-attenuated inversion recovery, GM=gray matter, Mfs=maximum fractal scale, mfs=minimum fractal scale, WM=white
matter). Demographic variables (age, sex and level of education) have been inserted as additional predictors to model possible residual effects in the patient
population.
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2.3. MRI examination
All subjects were examined on a clinical 1.5 T system (Intera, Philips
Medical System, Best, The Netherlands) equipped with 33 mT/m
maximum gradient strength and a 6-channel head coil. After the scout
image, sagittal 3D T1-weighted turbo gradient echo [repetition time
(TR)= 8.1ms, echo time (TE)= 3.7ms, flip angle= 8°, inversion
time=764ms, field of view (FOV)= 256mm×256mm, matrix
size= 256×256, 160 contiguous slices, slice thickness= 1mm]
images were acquired for WM and cortical GM segmentation.
The MR examination protocol included an axial T2-weighted FLAIR
sequence (TR=11,000ms, TE=140ms, inversion time
(TI)= 2800ms, flip angle= 90°, FOV=250mm×250mm, matrix
size= 280×202, 40 contiguous slices, slice thickness= 3mm, inter-
slice gap=0.6mm) and an axial T2*-weighted gradient-echo sequence
[TR=696ms, TE=23ms, flip angle= 18°, FOV=250mm×
200mm, matrix= 252×160; 22 slices; slice thickness= 5mm; in-
terslice gap= 1mm; number of excitations (NEX)=2].
All images were visually assessed by an experienced neuroradiolo-
gist in order to identify possible artifacts. After this visual quality
control, all images were used for further processing.
2.4. Neuroimaging feature extraction
A general overview of the neuroimaging feature extraction proce-
dure is shown in Fig. 1.
2.4.1. Standard neuroimaging features of small vessel disease
For the purposes of the present study, we decided to focus on the
main MRI SVD-related markers, i.e., white matter hyperintensities, la-
cunes, enlarged perivascular spaces, and cerebral microbleeds, that
were evaluated according to the conventional and quantitative MRI
methods applied within the Vascular MCI-Tuscany Study. While la-
cunes, EPVS and cerebral microbleeds have been conventionally eval-
uated according to standard visual rating approaches centrally per-
formed by an experienced neurologist, the WMH have been
quantitatively expressed as the lesion load.
Lacunar infarcts were defined as cavities 3 to 10mm in diameter
mostly ovoid/spheroid, and were categorized as 0= (absent),
1= (1–3), 3= (> 3).
Microbleeds were defined as small, rounded or circular, well-de-
fined hypointense lesions within brain tissue ranging from 2 to 10mm
in diameter; the Microbleed Anatomical Rating Scale (MARS) was used
to assess the total number of microbleeds (Gregoire et al., 2009).
Enlarged perivascular spaces were defined as small, sharply deli-
neated structures of cerebrospinal fluid intensity on imaging that fol-
lowed the orientation of the perforating vessels, ran perpendicular to
the brain surface, and were < 3mm wide. EPVS have been assessed in
the basal ganglia and centrum semiovale, and were coded as 0= (ab-
sent), 1= (≤10), 2= (11−20), 3= (21–40), and 4= (≥40).
A single observer outlined the T2-hyperintense WM lesions on FLAIR
images of all patients with SVD and MCI using a semiautomated seg-
mentation technique based on user-supervised local thresholding (Jim
5.0, Xinapse System, Leicester, UK; www.xinapse.com/Manual/). We
thus defined the WM lesion load as the total lesions volume normalized
by the individual cerebral WM volume (see Section 2.4.2White and gray
matter volumes sub-section below).
Fig. 2. Example of a WM and a cortical GM seg-
mentation mask in one patient with SVD and MCI. A)
A 3-D view of the GM/WM interface surface; B) A
coronal slice of the WM volume mask; C) The log-log
plot of N(r) counts vs. cube side r (mm) is shown for
the cerebral WM volume mask. The regression line,
which showed the highest R2adj (0.9999) and a sign
changed slope (i.e., FD) equal to 2.4530, is also su-
perimposed. The WM mfs was 21=2mm and the
WM Mfs was 25= 32mm; D) A 3-D view of the pial
surface; E) A coronal slice of the GM volume mask; F)
The log-log plot of N(r) counts vs. cube side r (mm) is
shown for the cortical GM volume mask. The re-
gression line, which showed the highest R2adj
(0.9996) and a sign changed slope (i.e., FD) equal to
2.4429, is also superimposed. The GM mfs was
20= 1mm and the GM Mfs was 25=32mm.
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2.4.2. White and gray matters volumes
Cortical reconstruction and volumetric segmentation was performed
with the FreeSurfer image analysis suite v. 5.3, which is documented
and freely available (http://surfer.nmr.mgh.harvard.edu/). The tech-
nical details of these procedures are described in prior publications
(Fischl, 2012). All the FreeSurfer outputs were visually inspected for
defects: all planes (coronal, sagittal and axial) were examined to eval-
uate segmentation and surfaces reconstruction errors. We applied the
correction procedures proposed by the FreeSurfer developers, consisting
of both editing of brain and WM masks and adding control points and
re-running of the FreeSurfer pipeline (https://surfer.nmr.mgh.harvard.
edu/fswiki/FsTutorial/TroubleshootingData). The manual editing of a
single operator and re-running was carried out up to three times to
assure that all defects were corrected (McCarthy et al., 2015).
Volumes of cerebral WM, cortical GM and estimated intracranial
volume (eTIV) were also computed. To reduce the effect of brain size,
both WM and GM volumes were normalized to eTIV.
2.4.3. White and gray matter fractal analysis
We investigated both the FD of the cerebral WM and of the cerebral
cortical GM. Among different methods to compute the FD, we chose the
box counting algorithm, which is a fairly direct and reliable method to
analyze fractal objects (Esteban et al., 2007; Mustafa et al., 2012; Zhang
et al., 2006). Briefly, a grid composed of 3-D cubes of side r has been
overlapped to the brain region of interest (WM or cortical GM) and the
number of intersections N(r) between the grid and the brain region has
been counted (Falconer, 2005). This process was iterated for different r
values, with a uniform distribution in a logarithm scale (r=2k voxels,
where k=0, 1, …, 8 in this work). As suggested by Goñi and colleagues
(Goñi et al., 2013), 20 random offsets with a uniform distribution were
placed on the origin of the 3-D grid and the mean value of all the in-
tersections (one for each offset value) has been calculated to extract a
single N(r) for each r value. Then, we plotted N(r) against r in a bi-
logarithm plane and the FD has been calculated as the absolute value of
the slope of the linear regression. This linear relationship in the bi-
logarithm plane is equivalent to a power law N(r)=K r– FD in the
natural scale, where FD, the fractal dimension, is the exponent (with a
negative sign) and K is the prefactor (Mandelbrot, 1982).
Generally, a brain structure shows its fractal properties in an in-
terval of spatial scales, which is unknown a priori. Therefore, in this
study, we applied an automated selection of spatial scales, for each
brain region, looking for the interval in which the linear regression
exhibits the best fit, as determined by the highest coefficient of de-
termination (adjusted for the number of data points) R2adj using the same
approach adopted previously (Marzi et al., 2018). Both the minimum
fractal scale (mfs) and the maximum fractal scale (Mfs) of WM and
cortical GM have been also considered as potential predictors of cog-
nitive scores. An example of a WM and a cortical GM segmentation
mask in one patient with SVD and MCI is shown in Fig. 2.
To assess the accuracy of our method for the computation of the FD
using an automated selection of the spatial scales, the proposed im-
plementation has been preliminarily applied to binary synthetic volu-
metric images with known FD, obtaining a percentage relative
error < 3% (see Supplementary Appendix and Supplementary
Table 1). The FD computation was implemented in custom scripts de-
veloped in C++ and Bash languages and in MATLAB environment
(R2018a, MathWorks, Natick, MA, USA) under a Linux operating
system.
2.5. Descriptive statistics and between-group analysis
Descriptive analyses were carried out to characterize the sample in
terms of socio-demographic, cognitive scores and neuroimaging fea-
tures. We also compared WM and GM volumes, fractal dimensions and
minimum and maximum scales between healthy controls and patients
using a Mann Whitney test corrected for multiple comparisons with the
Holm-Bonferroni procedure (to control the family-wise error rate) using
a corrected significance p-value< .05.
2.6. LASSO regression
We fitted a separate regression model for each neuropsychological
test. In particular, we studied the potential of all neuroimaging features
(see Fig. 1) in predicting cognitive adjusted scores using the least-
square linear regression with regularization by the L1-norm (LASSO
regression method) (Hastie et al., 2013). In detail, we determined the
fitted regression coefficients β^ by minimizing the residual sum of
squares plus a penalty term proportional to the L1-norm of the coeffi-
cients: = +( )y X^ ( ) argmin N12 22 1 ,where α is a positive
weighting parameter on the L1 penalty, X the vector of explanatory
variables (neuroimaging and demographic features), ∥∥1the L1-norm,
∥∥2 the L2-norm and N the number of samples (patients) used for fitting.
The α penalty weights the degree of sparsity, so that higher values of α
enforce sparsity in the regression coefficients, i.e., drive more coeffi-
cients in the model to be exactly zero. In this way, the regression fit and
feature selection are carried out at the same time.
For each model, in order to reduce the possibility of overfitting and
for hyperparameter (α weight) optimization, the regression task was
performed in a nested 10-fold cross-validation (CV) loop (Mueller and
Guido, 2017). In this procedure, for each fold of the outer 10-fold CV,
the training set is used for an inner 10-fold CV in order to evaluate the
performance of the inner classifier while varying the α penalty term in
the set {h× 10p, 1}, where h= {1, 2, …, 9} and p= {−4, −3, −2,
−1}. Once α value that minimized the out-of-sample prediction error
(Hastie et al., 2013) has been found in the inner CV, the model with that
α value is re-trained on the outer training set and tested on the test set
kept out from the outer CV. This procedure is repeated for each fold of
the outer CV. Before each training of the LASSO regression (both in the
inner and in the outer CV), each feature was standardized with re-
ference to the training set only. Test set data were not used in any way
during the learning process, thus preventing any form of peeking effect
(Diciotti et al., 2013). Performance was quantified in terms of the
Pearson correlation coefficient between predicted and actual values of
the neuropsychological test computed on the test set of the outer CV.
Since the selected features may vary depending on how the data are
split in each fold of the CV, for each neuropsychological test, we re-
peated the nested CV procedure 1000 times recording the frequency
that each feature was selected and the sign of the regression coefficient
estimates from each fold of the round of the outer CV. In fact, the
frequency of selection of a feature indicates to what extent that feature
is more likely to be included in the model and the 1000 repetitions
allow investigating a robust statistical association between neu-
ropsychological scores and features. Average and standard deviation of
the results from all repetitions (correlation coefficients r between real
and predicted labels in the test set of the outer CV) were computed to
get a final model assessment score.
For each neuropsychological test, statistical significance of predic-
tion performance was determined via permutation analysis – re-
commended especially when the sample size is small (Noirhomme
et al., 2014). Thus, for each neuropsychological test, 5000 new models
were created using a random permutation of the labels (i.e., neu-
ropsychological scores), such that the explanatory variables were dis-
sociated from its corresponding neuropsychological score, to simulate
the null distribution of the performance measure against which the
observed value was tested (Nichols and Holmes, 2002). Correlations
were considered significant if the p-value computed using permutation
tests was< 0.05.
We used own code developed in Python programming language
(release 3.7.1, available at https://www.python.org/) for data analysis.
In particular, the linear regression model was implemented by using the
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LassoCV function of the scikit-learn module (version 0.20.1).
3. Results
The computational analyses performed for the extraction of ad-
vanced neuroimaging features were carried out on a Dell PowerEdge
T620 workstation equipped with two 8-core Intel Xeon E5–2640 v2, for
a total of 32 CPU threads, and 128 GB RAM, using the Oracle Grid
Engine batch-queuing system. For each subject, the processing time
required approximately 30min for the quantification of WM lesions
volume, 9 h of a single core CPU time (with additional ~5 h after each
manual editing) for FreeSurfer segmentation, and about 2min for the
calculation of both WM FD and GM FD. The total computation time for
the 1000 nested CV loop and 5000 random permutations for all neu-
ropsychological tests was about 3 h on a single core of a Linux work-
station equipped with a 4-core (8 threads) INTEL i7-7700K CPU and
64 GB RAM.
3.1. Descriptive statistics and between-group analysis
Distributions of the neuropsychological tests mean and SD adjusted
scores, and percentages of patients with an abnormal performance in
each test are shown in Table 1. Four patients did not complete the TMT-
A and one the immediate copy of the ROCF. Percentage of abnormal
performance in all tests ranged from 39 to 47%, except for the Rey–-
Osterrieth Complex Figure, with an abnormal performance in 78% of
patients.
Descriptive statistics of neuroimaging features and available com-
parisons between healthy subjects and patients with SVD and MCI have
been reported in Table 2. All features extracted using fractal analysis
(minimum scale, maximum scale, and FD) of both WM and cortical GM
in patients have also been listed in the Supplementary Table 2.
As compared to healthy controls, the group of patients with SVD and
MCI showed significantly reduced WM FD and GM normalized cortical
volume and increased minimum spatial scale of GM.
3.2. LASSO regression
In Table 3, the results obtained for all LASSO regression models are
displayed. We found that the statistically significant models were those
for MoCA (r=0.321, p-value= .039), SDMT (r=0.324, p-
value= .039) and TMT-A (r=0.354, p-value= .025). Significant
prediction above-chance of these scores was obtained using different
sets of neuroimaging features. A ranking of all neuroimaging features
according to the LASSO feature selection frequency is shown in Fig. 3.
The average frequency, among significant models (MoCA, SDMT and
TMT-A scores), with which each feature was selected (regression
coefficient different from zero) across all outer CV folds in 1000 re-
petitions of LASSO regression is shown in Fig. 4. The WM FD was the
most frequent feature consistently selected in the significant models.
Finally, Table 4 shows the neuroimaging features selected with
frequency > 80% based on 1000 repetitions of the nested CV along
with the direction (positive/negative) of the most frequent sign of the
corresponding regression coefficient. The WM FD was the only feature
consistently selected in all three models.
4. Discussion
4.1. Potentials of WM FD in predicting cognitive performance in patients
with SVD and MCI
In this study of patients with SVD and MCI, we used the capability of
machine learning in predicting neuropsychological scores on tests
sensitive to attention and executive dysfunctions. We found that WM
FD was, on average, the feature most consistently selected for pre-
dicting neuropsychological scores among the statistically significant
models. The WM FD was significantly reduced in patients with SVD and
MCI as compared to healthy controls. Also, among the significantly
predicted scores, we observed that the trend of the relationship between
the WM FD and cognitive performance is univocal. Accordingly, a de-
crease in WM FD, i.e., a reduction of structural complexity of WM, was
associated with a worsening in cognitive performance. It is conceivable
that cognitive impairment observed in patients with subcortical WM
damage associated with SVD derives from the effect of a diffuse cor-
tical-subcortical disconnection syndrome rather than from a localized
mere tissue loss. Of note, in our study, the WM volume was a negligibly
selected feature - the latest in feature ranking. We submit the hypoth-
esis that FD represents a marker of global disarrangement of the WM in
SVD patients. These pieces of evidence are in line with a previous study
in healthy subjects in which individuals with reduced WM FD had lower
intelligence scores and more age-related cognitive decline (Mustafa
et al., 2012).
As compared to healthy controls, the group of patients with SVD and
MCI also showed a significantly higher minimum spatial scale of the
cortical GM, automatically determined by the fractal analysis.
Consistently, in the patient group, the GMmfs increased when cognitive
performance was worsened. A recent study analyzed the minimum and
maximum spatial scales in healthy subjects (Krohn et al., 2019). Al-
though ours and Krohn et al. studies differ for some methodological and
pre-processing differences, we observed a similar preference of the
automatic selection of spatial scales for smaller minimal scales and
shorter interval lengths (number of data points employed in the se-
lected scale range). Indeed, in the patient sample, the most frequent
combinations were, for WM, mfs= 1mm and interval length= 5 data
points and mfs= 2mm and interval lenght= 4 data points, while, for
GM, mfs= 2mm and interval length=5 data points (see Supplemen-
tary Table 2). However, further studies are needed to investigate the
impact of each disease condition on the spatial scales. In our patient
sample, we hypothesize that the behavior of the GM mfs might reflect
an initial disruption of the cortical GM – which is known to be present
in this patient population (Wardlaw et al., 2013), and is also in line with
the reduced GM normalized cortical volume – at a finer spatial scale.
4.2. WM FD as a feature of structural complexity
The WM FD assumes a fractional value between 2 and 3, capturing
Table 1
Distributions of the neuropsychological tests adjusted scores and of percentages of patients with an abnormal performance.
Neuropsychological test Number of patients Patients with an abnormal performance
(%)
Mean (standard deviation) Min, max
Montreal cognitive assessment 64 28 (44%) 20.6 (4.5) 11.95, 29.29
Visual search 64 27 (42%) 31.8 (8.5) 14.3, 50.17
Symbol digit modalities test 64 27 (42%) 36.9 (9.6) 22.02, 59.04
Color word stroop test 64 30 (47%) 38.5 (28.7) −3.45, 155.09
Trail making test - part A 60 25 (39%) 62.3 (46.4) 3.77, 202.2
Rey–osterrieth complex figure
(immediate copy)
63 49 (78%) 22.9 (8.3) 4, 36
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the structural complexity of a highly complex object which fills the
space more than a smooth surface (2-dimensional), but less than a filled
volumetric structure (3-dimensional). In our study, we observed a mean
FD of cerebral WM of 2.4650 in patients with cerebral SVD and MCI
that was significantly lower than that observed in healthy controls. The
WM FD has been also computed in other neurological diseases. Esteban
et al. demonstrated that the cerebral WM FD was lower in patients with
multiple sclerosis as compared to controls (Esteban et al., 2007; Esteban
et al., 2009). In another study, the FD of the cortical GM/WM interface
was significantly reduced in patients with epilepsy (Cook et al., 1995).
Multifractal properties of WM abnormalities in healthy elderly subjects
have also been recognized in T2-weighted images (Takahashi et al.,
2009), also in in relation to early-stage atherosclerosis (Takahashi et al.,
2006).
Similarly to the FD of the cortical ribbon (King et al., 2010), the
value of the WM FD may depend not only on volumetric changes of
subcortical WM, but also on volumetric changes of basal ganglia and
lateral ventricles. This is due to the fact that both FDs (of cortical ribbon
and WM) are affected by alterations of the GM/WM interface. Ven-
tricular enlargement of lateral ventricles has been described in patients
with SVD (Jokinen et al., 2012). We are not aware of studies reporting
basal ganglia volume loss in SVD even though this possibility might
exist.
4.3. FD as a complementary feature in the SVD research field
Our results suggest that the WM FD might be a marker of cognitive
performance in patients with SVD and MCI. This result has potentially
relevant implications. In fact, FD is a measurement that can be com-
puted in the field of SVD research using standard high-resolution T1-
weighted imaging and does not require further dedicated acquisitions.
We observed that also other features obtained from quantitative neu-
roimaging procedures (e.g., WM lesion load) provided predictive value
beyond what is available from visual rating of standard features in SVD,
which are likely to be easier and less expensive to assess.
Besides WM FD, neuroimaging features frequently selected (> 80%)
in our sample of SVD MCI patients included WM lesions load, GM vo-
lume, GM mfs, cerebral microbleeds, GM FD, lacunar infarcts, WM Mfs
and GM Mfs. Of note, the degree of importance of these features varied
across different neuropsychological scores. Overall, the results suggest
that the models for prediction of MoCA and SDMT scores are sparser as
compared to that obtained for TMT-A. As expected, due to the inherent
complexity of the behavioral measurement of cognitive performance,
the obtained results also support the view that more than one
Table 2
Descriptive statistics of neuroimaging features [mean (SD), minimum and maximum values], and comparisons between healthy subjects and patients with SVD and
MCI.
Feature Healthy subjects
(N=24)
Patients with SVD and MCI
(N=64)b
P-value
(corrected)
Standard features Visual rating Lacunar infarcts (categorical)c 0 2.09 (0.81)
[1–3]
NA
Microbleeds (number) – 1.27 (3.71)
[0–18]
NA
EPVS basal ganglia (categorical)° – 1.72 (0.77)
[0–4]
NA
EPVS centrum semiovale (categorical)° – 1.77 (0.77)
[1–3]
NA
Quantitative WM lesion load (unitless) – 0.07 (0.05)
[0.01–0.20]
NA
Volumes GM volume (unitless) 0.24 (0.02)
[0.21–0.28]
0.23 (0.02)
[0.20–0.27]
0.002 (0.015)a
WM volume (unitless) 0.30 (0.02)
[0.25–0.32]
0.29 (0.02)
[0.24–0.34]
0.040 (0.161)
Fractal analysis GM FD (unitless) 2.4407 (0.0203)
[2.4010–2.4819]
2.4359 (0.0167)
[2.3969–2.4746]
0.097 (0.120)
GM mfs (mm) 1.83 (0.64)
[1–4]
2.13 (0.50)
[2–4]
7×10−4(0.006)a
GM Mfs (mm) 31.3 (3.27)
[16–32]
31.5 (2.81)
[16–32]
0.412 (0.412)
WM FD (unitless) 2.4874 (0.0311)
[2.4135–2.5297]
2.4650 (0.0341)
[2.3960–2.5316]
0.002 (0.015)a
WM mfs (mm) 1.67 (0.48)
[1–2]
1.48 (0.50)
[1–2]
0.070 (0.120)
WM Mfs (mm) 16.67 (3.27)
[16–32]
20.25 (7.12)
[16–32]
0.011 (0.054)
EPVS= enlarged perivascular spaces, FD= fractal dimension, GM=gray matter, Mfs=maximum fractal scale, mfs=minimum fractal scale, N=number of
participants, NA=not applicable, SD= standard deviation, WM=white matter. WM and GM volumes are normalized to the estimated intracranial volume.
a Significant at a Mann Whitney test corrected for multiple comparison with the Holm-Bonferroni procedure (to control the family-wise error rate) using a
corrected significance p-value< .05.
b Except for microbleeds, where N=63.
c 0= (absent), 1= (1–3), 3= (>3).° 0= (absent), 1= (≤10), 2= (11–20), 3= (21–40), 4= (≥40). - = not measured.
Table 3
Mean and standard deviation of the Pearson coefficient of correlation r between
the LASSO predicted values of the test set of the outer CV and the actual values
using 1000 repetitions of the nested 10-fold CV. P-values indicate the prob-
ability that the empirical r score could arise by chance. They have been com-
puted using 5000 permuted-data CV scores simulating the null distribution.
Neuropsychological test Mean r (SD) p-value
MoCA 0.321 (0.079) 0.039⁎
Visual search 0.106 (0.091) 0.318
SDMT 0.324 (0.073) 0.039⁎
TMT-A 0.354 (0.094) 0.025⁎
Stroop 0.222 (0.082) 0.106
ROC-F immediate copy 0.295 (0.090) 0.090
MoCA, montreal cognitive assessment; ROC-F, Rey–Osterrieth complex figure;
SD, standard deviation; SDMT, symbol digit modalities test; TMT-A, trail
making test - part A.
⁎ Significant at the permutation-test using a significant p-value< .05.
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neuroimaging feature is needed to reliably predict cognitive scores in
this patient population and that, in general, different sets of features
may be required to predict different scores. This is in accordance with
the fact that these features quantify complementary aspects of SVD-
related modifications occurring in the brain. In particular, the joint
analysis through the FD and brain volumes might provide greater
prediction abilities than the use of each measurement separately (King
et al., 2009). In fact, it is well known that the FD and volume examine
and quantify different structural aspects, thus generally being com-
plementary to each other (Farahibozorg et al., 2015; Free et al., 1996;
King et al., 2009).
Taken together, our data suggest that different neuroimaging tools
should be used when evaluating the cerebral cortex and the subcortical
WM to obtain significant outcomes.
4.4. Methodological considerations
We explored predictive abilities of a wide set of standard and ad-
vanced neuroimaging features with a machine learning approach (using
the out-of-sample error), in line with the goals of achieving the clinical
diagnosis on an individual basis. This approach is different from the
conventional linear regression analysis applied to the entire data set in
which the possibility of overfitting may not be negligible. In particular,
we used LASSO regression in order to perform, at the same time, a
multivariate linear regression and feature selection.
Considering the exploratory nature of our study, mainly aimed at
Fig. 3. Ranking of LASSO-based neuroimaging feature selection. For each significant model, the frequency with which each feature was selected (coefficient different
from zero) across all outer CV folds in 1000 repetitions of LASSO regression is shown. The features have been reordered based on the occurring average frequencies.
Red bars indicate the frequency with which the corresponding coefficient was positive (direct association with the neuropsychological scores) – whereas blue bars,
the frequency with which the corresponding coefficient was negative (inverse association with the neuropsychological scores).
Fig. 4. The average frequency among MoCA, SDMT and TMT-A tests with
which each neuroimaging feature was selected (coefficient different from zero)
across all outer CV folds in 1000 repetitions of LASSO regression among MoCA,
SDMT and TMT-A tests is shown.
Table 4
Neuroimaging features selected with frequency > 80% based on 1000 repetitions of the nested cross-validation along with the direction (positive/negative) of the
most frequent sign of the regression coefficient have been reported. For each neuropsychological test, the score interpretation has been also indicated.
Neuropsychological test Cognitive scores interpretation
(worst to best performance)
Relevant features
MoCA Low to high values WM FD (+), WM lesions load (−)
SDMT Low to high values WM FD (+), GM volume (+), GM mfs (−)
TMT-A High to low values Cerebral microbleeds (+), Lacunar infarcts (−), WM FD (−), GM FD (−),GM mfs (+), GM Mfs (−), WM lesions load
(+), WM Mfs (−)
MoCA, montreal cognitive assessment; SDMT, symbol digit modalities test; TMT-A, trail making test - part A.
(+): a positive direction of the regression coefficient sign indicating a direct association.
(−): a negative direction of the regression coefficient sign indicating an inverse association.
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evaluating the possible role of WM FD as an additional MRI marker
potentially associated with cognitive performance in SVD, we repeated
the same model of analysis on several cognitive tests to explore the
consistency of the associations across 1) different measurements within
the same cognitive domain and 2) several rounds of a nested CV loop
(1000 repetitions). In particular, we chose a 10-fold CV because it offers
a favorable bias-variance trade-off (Hastie et al., 2013; Lemm et al.,
2011) and is also adequate for model selection (Breiman and Spector,
1992). Fitting all neuropsychological scores simultaneously into a
single comprehensive model could also be carried out, but it would
probably require a larger dataset in order to learn the different and
complex pattern of associations among neuropsychological scores and
neuroimaging features.
We considered the main standard features in SVD research in order
to take into account important explanatory variables in the models,
such as the WM lesion load (accounting for lesions extent), cerebral
microbleeds, EPVS, and lacunes. WM and GM volumes have been in-
troduced in the analysis to further consider the impact of macroscopic
structural alterations, such as brain atrophy, on cognitive performance.
The effect of age, sex, and education has been accounted for using
neuropsychological scores corrected according to normative data and
using demographic variables as predictors in the models to account for
potential residual effects in the patient population. We used both
standard and advanced neuroimaging features; in particular, we
adopted an algorithm for the estimation of the FD using an automated
selection of the spatial scales (Marzi et al., 2018), which showed good
accuracy on synthetic structures.
We feel that the fact that both mfs and Mfs vary across patients with
SVD and MCI does not limit the between-scan comparability. In fact,
each patient has been studied in his/her optimal range of spatial scales,
automatically determined according to the maximization of a best-fit
regression. Moreover, spatial scales are 1-D measurements like cortical
thickness and we feel that spatial scales should not be normalized,
following recommendations suggested for cortical thickness (Ad-
Dab'bagh et al., 2005; Schwarz et al., 2016). However, future studies
should examine this aspect in more detail.
4.5. Limitation and future developments
We enrolled a rather small number of patients. Therefore, our re-
sults need to be confirmed in other studies using independent and larger
samples. The number of included patients also restricted the possibility
of performing analyses with a larger number of neuropsychological
tests assessing also different cognitive domains, and with a larger set of
neuroimaging features. We thus decided to limit our analyses to tests
known to assess cognitive functions that are mainly affected in patients
with subcortical vascular disease and using a limited number of fea-
tures. Admittedly, a more extensive neuropsychological evaluation
could offer a more complete appreciation of the respective role of the
WM FD and other neuroimaging features in outlining cognitive deficits
in patients with SVD.
Our results suggest that, in a sample of patients with SVD and MCI, a
set of neuroimaging features (in which the WM FD was the most re-
levant) predicts cognitive performance and we feel that this is im-
portant per se for the SVD research field. At present, we are not able to
assess if such significant predictions are due to the SVD and/or MCI
condition. This could be investigated in future studies in which a
sample of patients with SVD only, a sample of patients with MCI only,
and a group of healthy controls will be examined using the same MRI
scanner and protocols and the same neuropsychological battery. A
larger sample group of healthy subjects would be also valuable for a
deeper investigation of possible associations of mfs and Mfs with aging
or cognition.
Future studies using longitudinal patient evaluations will in-
vestigate whether WM FD might represent an earlier marker of WM
damage.
Finally, in our study, we computed the FD of the general structure of
the WM. Future studies may explore the structural complexity of the
WM surface and WM skeleton. In particular, the skeleton retains pe-
culiar characteristics of the WM morphology (Liu et al., 2003) with a
reduced influence of atrophic changes of WM or surrounding brain
regions which may increase the variance of the FD estimates in the
sample population (Krohn et al., 2019). A joint FD analysis of WM
general structure, surface and skeleton may thus more completely
characterize the structural complexity of WM in both normal aging and
neurological diseases (Zhang et al., 2007).
5. Conclusions
We showed that a machine learning approach could be useful in
SVD using standard and advanced neuroimaging features. Our study
results raise the possibility that FD may represent a consistent feature in
predicting cognitive decline in SVD that can complement standard
imaging and clinical features in SVD.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nicl.2019.101990.
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